Suanovil 50

Verify with FDA CVM →

47 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
6
Deaths Reported
1280.0%
Death Rate

Active Ingredients

Suanovil 50

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 40
Cattle 6
Cat 1

Most Affected Breeds

Retriever - Labrador 9
Pit Bull 7
Retriever - Golden 4
Chihuahua 3
Holstein-Friesian also known as Holstein 3
Cattle (other) 3
Crossbred Canine/dog 3
Terrier - Cairn 2
Shepherd Dog (unspecified) 2
Pinscher - Miniature 2

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 10
Anorexia 6
Haematuria 6
Death 6
Restlessness 5
Diarrhoea 4
Weight loss 4
Glazed eye 4
Adipsia 4
Hyperkalaemia 4
Hyperglycaemia 4
Haemoglobinuria 4

Outcome Breakdown

Outcome Unknown
23 (43.4%)
Recovered/Normal
12 (22.6%)
Ongoing
7 (13.2%)
Died
6 (11.3%)
Recovered with Sequela
5 (9.4%)

Data Summary

Metric Value
Total adverse event reports 47
Reports involving death 6
Case-fatality rate (reported events) 1280.0%
Distinct species in reports 3
Distinct breeds in reports 18
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Suanovil 50 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 47 adverse event reports referencing Suanovil 50, including 6 reports in which the animal died — a 1280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Suanovil 50. Reported administration routes include Unknown, Oral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Suanovil 50 reports are Dog (40 reports), Cattle (6 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (9), Pit Bull (7), Retriever - Golden (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Suanovil 50 are Lethargy (see also Central nervous system depression in 'Neurological') (10), Anorexia (6), Haematuria (6), Death (6). Of the 53 reports with a coded outcome, Outcome Unknown is the leading category at 43.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Suanovil 50.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial